Humacyte, Inc. Quarterly Operating Income (Loss) in USD from Q3 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Humacyte, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q2 2024.
- Humacyte, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$29.5M, a 10.4% decline year-over-year.
- Humacyte, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$107M, a 14.3% decline year-over-year.
- Humacyte, Inc. annual Operating Income (Loss) for 2023 was -$100M, a 18.3% decline from 2022.
- Humacyte, Inc. annual Operating Income (Loss) for 2022 was -$84.6M, a 4.15% decline from 2021.
- Humacyte, Inc. annual Operating Income (Loss) for 2021 was -$81.2M, a 25.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)